de Pablo-Miró, M.; Pujol-Ruiz, S.; Iftimie, S.; Arenas-Miras, M.d.M.; López-Montesinos, I.; Duran-Jordà , X.; Anglès, A.; Grau, S.; Horcajada, J.P.
Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality. Antibiotics 2021, 10, 1296.
https://doi.org/10.3390/antibiotics10111296
AMA Style
de Pablo-Miró M, Pujol-Ruiz S, Iftimie S, Arenas-Miras MdM, López-Montesinos I, Duran-Jordà X, Anglès A, Grau S, Horcajada JP.
Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality. Antibiotics. 2021; 10(11):1296.
https://doi.org/10.3390/antibiotics10111296
Chicago/Turabian Style
de Pablo-Miró, Mar, Sergi Pujol-Ruiz, Simona Iftimie, MarÃa del Mar Arenas-Miras, Inmaculada López-Montesinos, Xavier Duran-Jordà , Albert Anglès, Santiago Grau, and Juan P. Horcajada.
2021. "Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality" Antibiotics 10, no. 11: 1296.
https://doi.org/10.3390/antibiotics10111296
APA Style
de Pablo-Miró, M., Pujol-Ruiz, S., Iftimie, S., Arenas-Miras, M. d. M., López-Montesinos, I., Duran-Jordà , X., Anglès, A., Grau, S., & Horcajada, J. P.
(2021). Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality. Antibiotics, 10(11), 1296.
https://doi.org/10.3390/antibiotics10111296